Diabetes in Focus

Diabetes in Focus
Second edition
Anjana Patel - Independent Pharmaceutical ConsultantIndependent Pharmaceutical Consultant

Diabetes mellitus is a common chronic disorder and represents a serious healthcare challenge. Its prevalence is increasing worldwide. Health outcomes for people with diabetes are strongly influenced by the quality of care received from health professionals following diagnosis.

This second edition of Diabetes in Focus details the practical pharmaceutical care that pharmacists can provide. In addition to the pharmaceutical assessment checklists, clear concise discussion is presented of the diabetic syndrome, screening and prevention, pharmacotherapeutic interventions and lifestyle management. New chapters are included on thiazolidinediones and meglitinides, Key aspects of clinical guidelines and National Service Framework for Diabetes are highlighted.

This book will be valuable to all pharmacists practising in a hospital or community environment, as well as to other health professionals working in the field of diabetes.

Reviews:
01-May-04, Annals of Pharmacotherapy:
"...the text provides a concise, easy-to-read, and clinically pertinent review of various aspects related to diabetes mellitus.'
Linda A Jaber PharmD, Associate Professor, Wayne State University, Detroit

13-Mar-04, The Pharmaceutical Journal:
'The information is in tune with current advice given by other diabetes professionals, with Diabetes UK, the diabetes national service framework, World Health Organization criteria for diagnosis and classification of diabetes and relevant National Institute for Clinical Excellence guidance.'
Irene Gummerson, Community Pharmacist

Contents:
1. Introduction: 2. The Diabetic Syndrome: 3. Prevention and Management of Diabetic Complications: 4. Lifestyle Management: 5. Monitoring Glycaemic Control: 6. Dietary Recommendations: 7. Pharmacotherapeutic Interventions with Antidiabetic Drugs: 8. Insulins: 9. Sulphonylureas: 10. Metformin: 11. Acarbose: 12. Thiazolidinediones: 13. Meglitinides: 14. New Therapies and Future Developments: 15. Prevention of and Screening for Diabetes Mellitus: 16. Pharmaceutical Assessment of People with Diabetes: Appendix 1. National Services Framework for Diabetes: Standards 2002: Appendix 2. Useful Resources: Glossary